This study also revealed that the antigenaemia of acute hepatitis-B patients can be interrupted by a transient seroconversion.
There are several techniques for the detection of antibody to hepatitis B surface antigen (anti-HBs). Techniques such as immunodiffusion and counterimmunoelectrophoresis have a relatively low sensitivity, but they are particularly useful for finding high-titre sera for specific immunoglobulin production. Passive haemagglutination (PHA) and radioimmunoassay (RIA) can detect much lower levels of anti-HBs. These methods are more appropriate for diagnostic purposes, such as in patients recovering from hepatitis B.
The significance of anti-HBs as an indicator of immunity against hepatitis B is not yet clear. But the use of reliable, sensitive, and easy techniques can contribute considerably to better knowledge in this matter. Both PHA and RIA have a limited accessibility for many laboratories, although they are both commercially available.
The principle of haemagglutination is simple, but, in practice, the present technique for anti-HBs detection is rather complicated. Moreover, the Received for publication 2 July 1979 sensitised erythrocytes have a very short shelf-life.
RIA can be performed only by well-equipped and licensed laboratories. The radioactive label has a limited shelf-life.
In this report we describe an enzyme-immunoassay (EIA) for the detection of anti-HBs using Hepanostika reagents, based on inhibition. This method can be particularly useful if Hepanostika is used as a screening test for hepatitis B surface antigen (HBsAg) and if a longer shelf-life is desired.
Material and methods

NORMAL HUMAN SERUM
Normal human serum was selected on the basis of the absence of HBsAg in enzyme-immunoassay and anti-HBs in radioimmunoassay. It was stored at -200C. STANDARD 
HBSAg
Human sera of subtype ad or ay were diluted 1:24 in 0 1 mol/l Na2HCO3 solution, heated for 10 hours at NaCl solution. The HBsAg content in these stock solutions was determined in nanograms HBsAg per millilitre by EIA on the basis of the 1st Panel of the National Reference Centre for virus hepatitis at the Institute of Hygiene of the University of Gottingen, West Germany. The HBsAg subtype was determined by immunodiffusion in agarose.
A stock solution of each subtype was stored at -20°C and thawed only once. Dilutions were made in 0-1 1/1 (1:10) normal human serum, containing 9 g/l NaCl, 0-1 mol/l glycine, and 1 g/l sodium azide.
They were stored at 2-8°C.
HUMAN ANTI-HBS
Human sera that were positive by immunodiffusion were used for the dilution series. The subspecificity was determined by immunodiffusion and by EIA, as previously described (Wolters et al., 1976 Figure 1 . This graph demonstrates that at 20'C procedure A gives the curve with the highest response, whereas procedure CI is the least sensitive. When in procedures A, B, and CI incubation with the sample was for 20 hours at 370C and all other incubations were for 2 hours at 370C (see Table 1 The patterns of antigenaemia and seroconversion in the 21 patients studied could be divided into two main types. This is shown in Figure 5 .
Fourteen patients of type I showed a reduction followed by a disappearance of HBsAg during reconvalescence. They all remained negative for HBsAg. Seroconversion was demonstrated by both EIA and RIA in at least 50%. In the seven type TT patients, reduction and disappearance of HBsAg was followed by a recurrence of the antigenaemia. During the HBsAg-negative period of four patients, anti-HBs was found by both ETA and RIA. Three Weeks after (Ist-) antigencemia Fig. 4 Anti-HBs in sera from 19 acute hepatitis B patients after their first antigenaemia (some patients had a recurrence of HBsAg, as was found in our previous study).
patients were also followed by PHA. Figure 6 shows the results of both PHA and EIA for antiHBs in the reconvalescent period in which seroconversion could be demonstrated by RIA. EIA became positive earlier than PHA in these patients. 1%.
'k.
group.bmj.com on October 29, 2017 -Published by http://jcp.bmj.com/ Downloaded from globulin were followed for up to 35 days. Neither subject had had anti-HBs, as judged by PHA, EIA, or RIA, before injection. Anti-HBs was no longer detected by PHA after six days in one individual or after 12 days in the other. EIA was still positive with standard antigen of both subtypes. Both subjects were still positive by RIA and EIA after 35 days, though by EIA only with standard antigen of subtype ad.
Discussion
In addition to screening for HBsAg, testing for anti-HBs is valuable in epidemiological studies and in monitoring patients and high-risk groups such as medical and laboratory staff in hospitals and renal dialysis units. Detection of anti-HBs is also useful for following the presence of passive immunity against hepatitis B in persons who have received specific immune globulin as prophylaxis. In the future. when active immunisation can be expected, tests for anti-HBs will give the first indication that immunisation has been effective.
Whereas the presence of HBsAg in blood is assumed to be an indication of replication of hepatitis B virus, the presence of anti-HBs is considered a marker for immunity against hepatitis B. It is not known to what extent very low levels of anti-HBs are protective. Nevertheless, the relativelyinsensitive immunodiffusion and counterimmunoelectrophoresis methods do not seem to be suitable for this purpose.
PHA and RIA, which are both commerically available, are certainly sufficiently sensitive. However, they have the disadvantage that at least some of the reagents are relatively unstable. Moreover, RIA has the usual disadvantages of working with radioactive isotopes, such as the disposal of radio--active waste, specially trained personnel, expensive laboratory facilities and equipment, and, in many countries, a special licence from the authorities.
An enzyme-immunoassay, as developed for the detection of HBsAg (Wolters et al., 1976) , has been shown to be a good alternative to RIA. The same reagents can be used for the detection of anti-HBs on the basis of inhibition of the HBsAg reaction by anti-HBs in the test sample.
We have tried to find the most sensitive modi--fication with minimal adaptations of the original EIA for HBsAg. Our results showed that preincubation of HBsAg with the test sample (procedure A) gives a higher sensitivity than a modification in which the HBsAg is already bound to the solid phase (procedures CI and CII) or a modification in which the anti-HBs is in competition with solidphase antibody (procedure B). Lange and Kohler (1978) Thirty sera found to be negative by RIA were also unreactive by EIA, indicating that falsepositive reactions are rare.
A follow-up study of hepatitis B patients demonstrated that RIA detected anti-HBs after disappearance of HBsAg in a number of patients earlier than EIA ( Fig. 4; Fig. 5 ). In at least 50% (7/14) seroconversion was demonstrated within the period of testing. Most EIA was more sensitive than PHA in this followup study (Fig. 6) . A similar conclusion can be drawn from the results in healthy individuals who had received an injection of anti-HBs-containing immunoglobulin.
This study has demonstrated that EIA for the detection of HBsAg can also be used as a test for anti-HBs. The direct sandwich RIA for anti-HBs using labelled HBsAg appeared to be more sensitive than an indirect EIA based on the inhibition of a sandwich assay for HBsAg.
The difference in sensitivity between the direct RIA and the EIA inhibition method was more pronounced in the dilution series than in the followup study of hepatitis B patients. We have no explanation for the phenomenon that anti-HBs dilutions giving P/N ratios of up to 60 by RIA were negative by EIA, whereas undiluted sera of patients giving similar P/N ratios were reactive by EIA. The latter comparison is, of course, more realistic. A direct sandwich test may be more sensitive, by definition, as the formation of a 'bridge' between solid-phase antigen and labelled antigen needs only one antibody, whereas for the neutralisation of a large antigen with many reactive sites many antibodies are necessary. A solid-phase RIA inhibition test for antiHBs has been described by others (Leonard et al., 1974; Muller et al., 1975; Pesendorfer, 1976; Forghani et al., 1977) . Forghani et al. (1977) detected slightly more anti-HBs sera with their method than by PHA. Pesendorfer (1976) found that his RIA inhibition method, which did not differ essentially from our test procedure with enzyme-labelled antibody, was only slightly less sensitive than the direct sandwich RIA (Ausab): the difference was a factor of about 3 on the basis of 50 % inhibition. This does not seem to support the above-mentioned hypothesis.
Although we may speculate that a direct sandwich EIA for anti-HBs will also be more sensitive than an EIA inhibition test, we conclude from our results that the latter method meets the current requirements for sensitivity. It can at least compete with PHA, which is widely accepted as a sensitive test. The EIA has the advantage that the reagents are stable for longer periods. An additional advantage is that screening for both HBsAg and anti-HBs can be done with the same reagents at the same time. 
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